STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13.
STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13.
复制标题
DOI:
10.1038/ncomms6798
复制
发表时间:
2014-12-15
影响因子:
16.6
通讯作者:
Watowich, Stephanie S.
中科院分区:
文献类型:
--
作者:
Zhang, Huiyuan;Hu, Hongbo;Greeley, Nathaniel;Jin, Jin;Matthews, Allison J.;Ohashi, Erika;Caetano, Mauricio S.;Li, Haiyan S.;Wu, Xuefeng;Mandal, Pijus K.;McMurray, John S.;Moghaddam, Seyed Javad;Sun, Shao-Cong;Watowich, Stephanie S.
The transcriptional regulator STAT3 curbs pro-inflammatory cytokine production mediated by NF-κB signaling in innate immune cells, yet the mechanism by which this occurs has been unclear. Here we identify STAT3 as a pivotal negative regulator of Ubc13, an E2 ubiquitin-conjugating enzyme that facilitates TRAF6 K63-linked ubiquitination and NF-κB activation. Ubc13 accumulates intracellularly in the absence of STAT3. Depletion of Ubc13 in Stat3-deficient macrophages subdues excessive RANKL- or LPS-dependent gene expression, indicating Ubc13 overexpression mediates enhanced transcriptional responses in the absence of STAT3. In RANKL-activated macrophages, STAT3 is stimulated by autocrine IL-6 and inhibits accrual of Ets-1, Set1 methyltransferase and trimethylation of histone H3 lysine 4 (H3K4me3) at the Ube2n (Ubc13) promoter. These results delineate a mechanism by which STAT3 operates as a transcriptional repressor on Ube2n, thus modulating NF-κB activity by regulation of Ubc13 abundance. Our data suggest this pathway plays important roles in bone homeostasis and restraint of inflammation.
登录
查看更多内容
影响因子:
32.4
作者:
Takeda, K;Clausen, BE;Akira, S
通讯作者:
Akira, S
影响因子:
50.3
作者:
Kortylewski M;Xin H;Kujawski M;Lee H;Liu Y;Harris T;Drake C;Pardoll D;Yu H
通讯作者:
Yu H
影响因子:
4.8
作者:
Duplomb, Laurence;Baud'huin, Marc;Heymann, Dominique
通讯作者:
Heymann, Dominique
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
10.5
作者:
Lomaga, MA;Yeh, WC;Mak, TW
通讯作者:
Mak, TW